RBC Capital上调CG Oncology (CGON)目标价从 72 美元上调至 84 美元

CG Oncology, Inc. (NASDAQ:CGON) also received a rating update from BofA on April 14. The firm lifted the price target on the stock to $84 from $72, maintaining a Buy rating on the shares. It stated that shares have run up 62% year-to-date with the acceleration of the timeline for PIVOT-006 IR NMIBC data, adding that the BofA is “still bullish at current levels” and sees “more room to run.” CG Oncology, Inc.

该内容为新闻快讯，正文已简化。